In 2012, Eurofarma has taken another important step aimed at broadening its actuation in Latin America by acquiring Merck Sharp & Dohme (MSD) in Colombia.
Eurofarma’s plans include, besides the outsourcing of the production of MSD, its main customer, also the commercialization of its own products in the country. The company looks for new commercial partners and outsourcing contacts, in order to improve the utilization of the factory and, at the same time, it has started the submission of dossiers in the country.
The plant acquired by Eurofarma is located in Bogota, capital of the country, and occupies an area of approximately 22 thousand square meters. Certified by INVIMA (National Institute of Food and Drug Surveillance) — a Colombian agency equivalent to the ANVISA (National Agency of Sanitary Surveillance) in Brazil — the plant produces powdered drugs, and also injectable, creams, liquid and solid drugs.